Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile  Wynnis L. Tom, Martin P. Playford, Shehla Admani, Balaji Natarajan, Aditya A. Joshi, Lawrence F. Eichenfield, Nehal N. Mehta  Journal of Investigative Dermatology  Volume 136, Issue 1, Pages 67-73 (January 2016) DOI: 10.1038/JID.2015.385 Copyright © 2015 The Authors Terms and Conditions

Figure 1 Cholesterol efflux capacity by psoriasis disease severity. (a) This diagram depicts efflux capacity by psoriasis severity as measured by percent body surface area (% BSA), with 15 subjects with <5% BSA affected and 29 with ≥5% BSA affected. (b) This diagram depicts efflux with psoriasis severity measured by the Psoriasis Area and Severity Index (PASI), with 26 subjects with PASI < 6 and 18 with PASI ≥ 6. Efflux capacity is expressed as a proportion normalized to a known pooled serum sample from five healthy volunteers (mean ± SD given; P-value derived from the t-test with equal variance). Journal of Investigative Dermatology 2016 136, 67-73DOI: (10.1038/JID.2015.385) Copyright © 2015 The Authors Terms and Conditions